The finalists for the C2 Catalyst for Precision Medicine Award significantly advance precision medicine in oncology to bring new, more personalized tests or treatments to cancer patients. As such, these finalists enhance the ability to provide the right treatment for the right patient at the right time. This year’s winner of the Annual C2 National Catalyst for Precision Medicine Award is Dr. Marc Matrana. “I’m thrilled to be the winner of this national award, ” Dr. Matrana says. “So many thanks to my phenomenal colleagues, family, and friends for making all of this possible. I am so proud to name the Cancer Advocacy Group of Louisiana (CAGLA) as the recipient of this $50,000 prize!”
Mission Statement: Cancer Advocacy Group of Louisiana (CAGLA) offers healthcare companies, doctors, and nonprofit organizations engaged in the fight against cancer the opportunity to connect with community leaders to advocate for policies that improve the lives of Cancer patients across Louisiana.
